Skip to main content
Article thumbnail
Location of Repository

Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses

By L Reilly, C Magkrioti, T Mduluza, DR Cavanagh and F Mutapi
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2654038
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1–2b trial in Papua New Guinea. J Infect Dis
    2. (1983). A reusable polyamide filter for diagnosis of S. haematobium infection by urine filtration. Bull Soc Pathol Exot Filiales
    3. (1972). A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo
    4. (1994). Anders RF: Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol Biochem Parasitol
    5. (2007). Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem Inst Oswaldo Cruz
    6. (1996). Applied multivariate techniques.
    7. (1995). Biometry: the principles and practice of statistics in biological research. Freeman and Company
    8. (1996). Chandiwana SK: Age-related antibody profiles in Schistosoma haematobium in a rural community in Zimbabwe. Parasite Immunol
    9. (2006). Co-infection of helminths and malaria: modulation of the immune responses to malaria. Parasite Immunol
    10. (2001). Coppel RL: Antibody responses to infections with strains of Plasmodium falciparum expressing diverse forms of merozoite surface protein 2. Infect Immun
    11. (2000). Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans. Parasite Immunol
    12. (2004). Druilhe P: Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar J
    13. (1994). Druilhe P: Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood
    14. (1998). Druilhe P: The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun
    15. (2008). Dunne DW: Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection. Infect Immun
    16. (1996). EM: Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen,
    17. (1998). EM: IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical malaria. Am J Trop Med Hyg
    18. (2004). G: Zimbabwe Roll Back malaria consultative mission (reaping).
    19. (2001). Heterogeneities in anti-schistosome humoral responses following chemotherapy. Trends Parasitol
    20. (2007). IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.
    21. (1998). JS: A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.
    22. (2004). KP: Association of house spraying with suppressed levels of drug resistance in Zimbabwe. Malar J
    23. (2006). Maizels RM: Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden. BMC Infect Dis
    24. (2004). McBride JS: Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun
    25. (1997). McBride JS: Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol Biochem Parasitol
    26. (1986). Mutambu SL: A review of the malaria situation in Zimbabwe with special reference to the period 1972–1981. Trans R Soc Trop Med Hyg
    27. (2000). Natural versus druginduced resistance in Schistosoma mansoni infection. Parasitol Today
    28. (1992). Plasmodium falciparum: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun
    29. (2005). Praziquantel treatment of people exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J Infect Dis
    30. (2002). RHails R: Modern statistics for the life sciences.
    31. (2002). Roddam A: p-values for pathogens: statistical inference from infectious-disease data. Lancet Infect Dis
    32. (1996). Roussilhon C: Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am J Trop Med Hyg
    33. (2006). Roussilhon C: Worms can alter T cell responses and induce regulatory T cells to experimental malaria vaccines. Vaccine
    34. (2000). Savioli L: The global status of schistosomiasis and its control. Acta Trop
    35. (2007). Schistosomiasis and malaria: another piece of the crossreactivity puzzle. Trends Parasitol
    36. (2004). Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol
    37. (2003). Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum.
    38. (2006). Sztein MB: Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children. Infect Immun
    39. (2006). T: Spatio-temporal analysis of the role of climate in inter-annual variation of malaria incidence in Zimbabwe.
    40. (1993). TF: Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol
    41. (1988). The antihelminthic action of praziquantel. Parasitol Today
    42. (2002). The economic and social burden of malaria. Nature
    43. (2005). Towards empirical description of malaria seasonality in southern Africa: the example of Zimbabwe. Trop Med Int Health
    44. (1998). Woolhouse MEJ: Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
    45. (1997). Woolhouse MEJ: Comparison of humoral responses to Schistosoma haematobium in areas with high and low levels of infection. Parasite Immunol

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.